ActiveSight, Lexicon Sign Second Protein Crystallography Service Agreement

ActiveSight announced that it has entered into a second protein crystallography services agreement with Lexicon Pharmaceuticals. The new agreement extends the co-crystallography of Lexicon's small molecule compounds to a second human drug target protein validated in-vivo by Lexicon and expressed by ActiveSight.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/04-27-2005/0003488859&EDATE=)